Today, Zacks Investment Ideas feature highlights Gilead Sciences GILD and Johnson & Johnson JNJ. Buy Gilead Sciences (GILD ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
2h
Zacks.com on MSNIs Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?Here is how Gilead Sciences (GILD) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.
Wall Street began the trading week on a negative note, with major market indices showing a decline as selling pressure ...
StockStory.org on MSN3h
1 Value Stock with Exciting Potential and 2 to IgnoreValue investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by ...
3h
Zacks Investment Research on MSNLLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia StudyEli Lilly LLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
LEN is a first-in-class, long-acting HIV-1 capsid inhibitor that disrupts multiple stages of the viral replication cycle. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results